Inhibikase Therapeutics, Inc. Common Stock

$1.87

Change

-0.04(-2.09%)

Volume

84.918K($158.62K)

Market Capitalization

$139.02M

Inhibikase Therapeutics Price Charts

Inhibikase Therapeutics Price Chart11:5 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM1.941.931.921.911.891.881.87

Inhibikase Therapeutics Market Segments

After Hours

*No Trades in Segment

Regular Trading Hours

-0.03(-1.58%)
Open$1.90
Close$1.87
Low$1.85
Low Change-0.05 (-2.63%)
High$1.98
High Change+0.08 (+4.21%)
Range$0.13
Volume83.169K
Dollar Volume$155.53K

Premarket

-0.15(-7.81%)
Open$1.92
Close$1.77
Low$1.77
Low Change-0.15 (-7.81%)
High$1.92
High Change+0.00 (+0.00%)
Range$0.15
Volume1.749K
Dollar Volume$3.10K

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

-0.05(-2.55%)
Open$1.96
Close$1.91
Low$1.90
Low Change-0.06 (-3.06%)
High$2.03
High Change+0.07 (+3.57%)
Range$0.13
Volume46.872K
Dollar Volume$89.53K

Premarket Yesterday

*No Trades in Segment

Inhibikase Therapeutics Stock Splits

There has been 1 stock split for Inhibikase Therapeutics (IKT). The reverse stock split occured on June 30, 2023 and reduced the outstanding shares at a ratio of 6:1.

DateTypeRatio
June 30, 2023Reverse6:1